Cancers, Vol. 13, Pages 3726: Glycosylation: Rising Potential for Prostate Cancer Evaluation

Cancers, Vol. 13, Pages 3726: Glycosylation: Rising Potential for Prostate Cancer Evaluation Cancers doi: 10.3390/cancers13153726 Authors: Anna Kałuża Justyna Szczykutowicz Mirosława Ferens-Sieczkowska Prostate cancer is the second most commonly diagnosed cancer among men. Alterations in protein glycosylation are confirmed to be a reliable hallmark of cancer. Prostate-specific antigen is the biomarker that is used most frequently for prostate cancer detection, although its lack of sensitivity and specificity results in many unnecessary biopsies. A wide range of glycosylation alterations in prostate cancer cells, including increased sialylation and fucosylation, can modify protein function and play a crucial role in many important biological processes in cancer, including cell signalling, adhesion, migration, and cellular metabolism. In this review, we summarize studies evaluating the prostate cancer associated glycosylation related alterations in sialylation, mainly α2,3-sialylation, core fucosylation, branched N-glycans, LacdiNAc group and presence of truncated O-glycans (sTn, sT antigen). Finally, we discuss the great potential to make use of glycans as diagnostic and prognostic biomarkers for prostate cancer.
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research